Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
Kappa and Lambda Light Chains - HealthTree for Multiple Myeloma
High Levels of Free Light Chains May Indicate Sooner MS Second Relapse
Frontiers | High levels of kappa free light chain synthesis predict cognitive decline in relapsing-remitting multiple sclerosis
Biomedicines | Free Full-Text | Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
free light chains ratio in AL amyloidosis, kappa and lambdaAmyloidosis Patient Information Site
Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis—from diagnosis to prediction of disease activity | Wiener Medizinische Wochenschrift
Living With - HealthTree for Multiple Myeloma
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Serum free light chain assessment in monoclonal gammopathy and kidney disease | Nature Reviews Nephrology
Light Chain Myeloma: Symptoms, Treatment, Outlook, More
N Latex FLC kappa & lambda Assays - Siemens Healthineers
Human Kappa Free Light Chain Assay | Diazyme Laboratories, Inc.
Medicina | Free Full-Text | The Use of Kappa Free Light Chains to Diagnose Multiple Sclerosis